Physician profile
Tri Pham
NPI 1548455686
$2,081.31
in general payments reported to CMS, 2019-2025
19 companies · $262 in 2025
The $262 reported for 2025 was more than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $732 · 2020: $277 · 2021: $113 · 2022: $162 · 2023: $265 · 2024: $271 · 2025: $262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $798.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $797.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $386.73 | 2019-2025 | Grafix Pl, Renasys Touch, Grafix |
| Merck Sharp & Dohme LLC | $263.74 | 2019-2020 | |
| Organogenesis INC. | $220.16 | 2022-2025 | Apligraf, Puraply, Affinity |
| Amgen INC. | $206.32 | 2019 | |
| Insmed, INC. | $189.76 | 2019-2024 | Arikayce |
| Astellas Pharma US INC | $133.82 | 2019-2020 | |
| Gilead Sciences, INC. | $128.92 | 2019-2025 | |
| Xeris Pharmaceuticals, INC. | $84.21 | 2022 | |
| Bioventus LLC | $77.97 | 2023 | |
| Melinta Therapeutics, LLC | $71.77 | 2019 | |
| Eisai INC. | $56.42 | 2021 | |
| Nabriva Therapeutics, Plc | $52.21 | 2020 | |
| Next Science LLC | $43.55 | 2024-2025 | Xperience, Blastx, Surgx |
| Janssen Biotech, INC. | $37.49 | 2019-2020 | |
| Convatec INC. | $34.78 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $33.78 | 2024 | Nuzyra |
| Allergan, INC. | $31.78 | 2019-2020 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $16.77 | 2020 | |
| Viiv Healthcare Company | $11.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tri Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.